TABLE 1.
Clinicopathological information of the patients in TCGA‐LIHC cohort and ICGC‐LIRI‐JP cohort
| Survival status | Total (N = 348) | ||
|---|---|---|---|
| Alive (N = 223) | Dead (N = 125) | ||
| Age (years old) | |||
| Mean (SD) | 58.4 (12.9) | 61.2 (13.7) | 59.4 (13.2) |
| Median [Min, Max] | 60.0 [16.0, 81.0] | 64.0 [18.0, 90.0] | 61.0 [16.0, 90.0] |
| Gender | |||
| Female | 61 | 49 | 110 |
| Male | 162 | 76 | 238 |
| Histological grade | |||
| G1 | 36 | 17 | 53 |
| G2 | 104 | 60 | 164 |
| G3 | 74 | 39 | 113 |
| G4 | 8 | 5 | 13 |
| AJCC TNM stage | |||
| Stage I | 126 | 39 | 165 |
| Stage II | 54 | 24 | 78 |
| Stage III | 36 | 45 | 81 |
| Stage IV | 0 | 3 | 3 |
| T stage | |||
| T1 | 129 | 43 | 172 |
| T2 | 57 | 28 | 85 |
| T3 | 32 | 43 | 75 |
| T4 | 3 | 10 | 13 |
| M stage | |||
| M0 | 170 | 80 | 250 |
| M1 | 0 | 3 | 3 |
| N stage | |||
| N0 | 166 | 78 | 244 |
| N1 | 1 | 2 | 3 |
| Survival status | Total (N = 256) | ||
|---|---|---|---|
| Alive (N = 214) | Dead (N = 42) | ||
| Age (years old) | |||
| Mean (SD) | 67.5 (10.2) | 66.9 (9.57) | 67.4 (10.1) |
| Median [Min, Max] | 69.0 [31.0, 89.0] | 68.5 [37.0, 83.0] | 69.0 [31.0, 89.0] |
| Gender | |||
| Female | 51 | 17 | 68 |
| Male | 163 | 25 | 188 |
| TNM stage | |||
| Stage I | 39 | 1 | 40 |
| Stage II | 99 | 18 | 117 |
| Stage III | 63 | 13 | 76 |
| Stage IV | 13 | 10 | 23 |
Abbreviations: AJCC, American Joint Committee on Cancer; G1, high differentiation; G2, medium differentiation; G3, low differentiation; G4, undifferentiated; LCSGJ, Liver Cancer Study Group of Japan.